SOMA 26 - Optimizing the Efficacy of Commonly Used Tactical Medical Gear and Medications In The Arctic Extreme Cold Operational Environment

<p>Recorded live at SOMA 26</p><p>Dr. Emily Johnston (Cascadia Mountain Institute) and SFC Ezequiel Mendoza (Arctic Dustoff, Fairbanks) deliver a hard-hitting, field-validated look at how standard tactical medical gear and medications actually perform—and fail—in true Arctic and extreme cold conditions. Drawing from cold-soak testing, simulated combat exercises, and real operational experience, they break down battery and fluid-warmer failures, rapid freezing of IV tubing and blood sets, medication storage realities, tourniquet performance, and the critical need for early frostbite interventions like ibuprofen and iloprost far forward. Practical fieldcraft solutions, insulation strategies, and clear calls for better-designed cold-weather medical systems are front and center.</p><p>Key Takeaways</p><ul><li>No electronic or mechanical medical device (IV pumps, Buddy Lite warmers, etc.) can be trusted to operate unprotected in Arctic conditions—insulate everything, including fluids and tubing.</li><li>Fluids and tubing freeze extremely quickly and become brittle; passive warming solutions using insulated containers + chemical heat packs can keep fluids viable for many hours even at –20°F to –30°F.</li><li>Body heat (base-layer transport systems worn against the skin) is the only reliably consistent way to prevent medication freezing during multi-day cold operations; outer pockets, med boxes, and sling packs routinely fail.</li><li>Current blood administration sets create major clotting and failure points in the cold; shorter, fully insulated, or redesigned kits are needed.</li><li>Most common tourniquets performed adequately after freeze-thaw cycles; metal windlasses held up better than plastic ones under extreme cold.</li><li>Reperfusion injury is the dominant mechanism of tissue loss in frostbite. Early NSAID (ibuprofen) loading and rapid iloprost administration dramatically improve outcomes, yet cold-chain and far-forward delivery of iloprost remain unsolved problems.</li><li>Manufacturer claims about extreme-cold performance often do not match real-world Arctic testing. Independent field validation is essential before relying on any device or medication in these environments.</li></ul><p>Chapters00:00 – Introduction &amp; Arctic strategic context</p><p>04:45 – Operational realities: long evacuation times and limited cold-weather experience</p><p>06:00 – Battery and device cold-soak testing (IV pump &amp; Buddy Lite)</p><p>09:20 – Functional testing: frozen pumps, ruptured warmer cartridges, and fluid output</p><p>11:40 – Practical insulation and pre-warming techniques for fluids</p><p>13:40 – Medication transport failures vs. base-layer body-heat solutions</p><p>18:50 – Blood product challenges and call for redesigned cold-weather kits</p><p>20:20 – Tourniquet performance after freeze-thaw cycles</p><p>21:15 – Frostbite pathophysiology and the critical role of early ibuprofen + iloprost</p><p>27:20 – Path forward: needed research, device redesign, and medication stability after freezing</p><p>29:40 – Closing remarks and Q&amp;A discussion</p><p>For more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠<a href="www.prolongedfieldcare.org">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a></p><p>Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠<a href="https://patreon.com/ProlongedFieldCareCollective">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a>⁠⁠⁠⁠⁠⁠ or ⁠<a href="https://www.lobocoffeeco.com/product-page/prolonged-field-care">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠⁠⁠⁠</a></p><p></p>